Read + Share
Amedeo Smart
Independent Medical Education
Schwartz DA, Peyrin-Biroulet L, Lasch K, Adsul S, et al. Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn's Disease: ENTERPRISE Study. Clin Gastroenterol Hepatol 2022;20:1059-1067.PMID: 34597729
Email
LinkedIn
Facebook
Twitter
Privacy Policy